FTC sues Shire ViroPharma for delaying generic competition
The Federal Trade Commission sued Shire ViroPharma for violating antitrust laws by abusing government processes to delay competition for its Vancocin capsules.
The agency alleged that the company waged a campaign...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch